Pharmaceuticals News

CAMBRIDGE, Mass. and COPENHAGEN, Denmark, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the...

Neil joins from Novo Nordisk and brings more than 20 years of experience in business development and strategic transactionsAppointment strengthens MitoRx’s business development capabilities as the...

BOSTON and SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and...

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on...

BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled...

Acquisition significantly expands the depth and scale of Evestia Clinical’s established medical writing capabilities for biotech innovators and pharmaceutical companiesThe deal expands Evestia...

Internet, Everywhere, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Shopify announced today financial results for the quarter ended September 30, 2026. Shopify achieved 32% revenue growth (32% in constant...

Vienna, Austria, Nov. 03, 2026 (GLOBE NEWSWIRE) -- QUANTRO Therapeutics GmbH, a pioneer in the discovery of transcription factor targeting therapies, announced today that the company received a...

With a goal of providing multiple data sets demonstrating differentiated efficacy and safety in multiple ANCA-associated vasculitis (AAV) settings, InflaRx intends to begin two Phase 2 trials in 2027,...

Peer-reviewed publication reports a 77% relative risk reduction in bloodstream infections and significantly lower systemic antibiotic exposure with SER-155 compared with placebo Translational data...